Month: July 2024

The collaboration between Argus ManuTech and MARS Bioimaging marks a significant step forward in the med-tech industry. By leveraging Argus ManuTech’s extensive manufacturing expertise and our groundbreaking imaging technology, the partnership promises to deliver advanced medical devices that set new benchmarks for quality and innovation. This alliance not only strengthens the capabilities of both companies but also supports the growth and advancement of New Zealand’s high-tech manufacturing sector.

In orthopaedic care, the precision of imaging is essential for diagnosing conditions, planning surgeries, and evaluating post-operative outcomes. MARS Bioimaging leverages cutting-edge technology to significantly reduce image artifacts, particularly in orthopaedic imaging.

A clinical trial for the MARS scanner at the Hospital for Special Surgery (HSS) in New York City has been approved to move forward by HSS’ institutional review board (IRB). This study marks the first US clinical trial for the MARS Scanner, set to commence in July 2024.